Otolith Device for Vestibular Migraine
(VIBRANT-VM Trial)
Trial Summary
Do I have to stop taking my current medications for the trial?
The trial mentions 'recent use of specified medications' as an exclusion criterion, but it doesn't specify which medications. It's unclear if you need to stop taking your current medications, so you should check with the trial organizers for more details.
How is the Otolith Labs Device treatment different from other treatments for vestibular migraine?
The Otolith Labs Device is unique because it uses nVRT Technology, which likely involves non-invasive vestibular stimulation to manage symptoms, unlike traditional medications that target migraine pain or vertigo separately. This device offers a novel approach by potentially addressing the vestibular (balance-related) component directly.12345
What is the purpose of this trial?
The goal of this clinical trial is to learn if the Otolith Labs device can improve vestibular function of subjects with vestibular migraine.The main questions it aims to answer are:* When the Otolith Labs device is on, are objective measures of the vestibular system better than when the device is off?* When the Otolith Labs device is on are subjective measures of the vestibular system better than when the device is off?* Are the objective measures related to the subjective measures?Researchers will change the order of the device settings to ensure the changes aren't due to the order they are tested.Participants will:* Wear the Otolith Labs device while in a rotary chair at different settings for different tests. All of the rotary chair testing will take less than an hour.* Answer questions about how the rotary chair testing made them feel for each test.* Answer questions about their every-day susceptibility to motion sickness and about their vestibular migraine symptoms.
Research Team
Didier Depireux, PhD
Principal Investigator
Otolith Labs
Eligibility Criteria
This trial is for individuals with vestibular migraines, a type of migraine that can cause dizziness and balance problems. Participants should be able to sit in a rotary chair and answer questions about their symptoms and susceptibility to motion sickness.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Testing
Participants undergo rotary chair testing with the Otolith Labs device at different power settings to evaluate vestibular function
Follow-up
Participants are monitored for safety and effectiveness after testing
Treatment Details
Interventions
- Otolith Labs Device
Otolith Labs Device is already approved in United States for the following indications:
- Vestibular Migraine
- Chronic Vertigo
- Meniere's Disease
- BPPV
Find a Clinic Near You
Who Is Running the Clinical Trial?
Otolith Labs
Lead Sponsor
Dizzy and Vertigo Institute of Los Angeles
Collaborator
Medical University of South Carolina
Collaborator